MYCN and neoplasm: It was recently demonstrated that in MYCN-amplified neuroblastoma cell lines, retinoic acid induces reprogramming of the ADRN CRC, leading to massive downregulation of MYCN expression, tumour suppression, and cell differentiation (Zimmerman et al., 2021).